SK121193A3 - Chewable antacid compositions - Google Patents

Chewable antacid compositions Download PDF

Info

Publication number
SK121193A3
SK121193A3 SK1211-93A SK121193A SK121193A3 SK 121193 A3 SK121193 A3 SK 121193A3 SK 121193 A SK121193 A SK 121193A SK 121193 A3 SK121193 A3 SK 121193A3
Authority
SK
Slovakia
Prior art keywords
granulated
magnesium
antacid
aluminum
carbonate
Prior art date
Application number
SK1211-93A
Other languages
English (en)
Slovak (sk)
Inventor
James G Upson
Carmelita M Russell
Paul R Court
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SK121193A3 publication Critical patent/SK121193A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SK1211-93A 1991-04-04 1992-03-13 Chewable antacid compositions SK121193A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68049891A 1991-04-04 1991-04-04
PCT/US1992/001982 WO1992017161A1 (en) 1991-04-04 1992-03-13 Chewable antacid compositions

Publications (1)

Publication Number Publication Date
SK121193A3 true SK121193A3 (en) 1994-07-06

Family

ID=24731369

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1211-93A SK121193A3 (en) 1991-04-04 1992-03-13 Chewable antacid compositions

Country Status (11)

Country Link
EP (1) EP0578732B1 (ja)
JP (1) JPH06505498A (ja)
AT (1) ATE139438T1 (ja)
AU (1) AU665944B2 (ja)
BR (1) BR9205824A (ja)
CA (1) CA2106216C (ja)
CZ (1) CZ225893A3 (ja)
DE (1) DE69211688T2 (ja)
HU (1) HUT65753A (ja)
SK (1) SK121193A3 (ja)
WO (1) WO1992017161A1 (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
JP3587869B2 (ja) * 1993-12-16 2004-11-10 グラクソ・スミスクライン株式会社 医薬組成物
WO1995025521A1 (en) * 1994-03-24 1995-09-28 The Procter & Gamble Company Solid dose forms containing bismuth
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
WO1995033469A1 (fr) * 1994-06-06 1995-12-14 Yamanouchi Pharmaceutical Co., Ltd. Antiacide solide et procede de production de ce compose
AU3132495A (en) * 1994-07-20 1996-02-16 American Home Products Corporation Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids
IT1274735B (it) * 1994-08-25 1997-07-24 Enosys S P A Farmaco e vettore per le patologie infiammatorie ed erosive del tratto gastrointestinale a base di sucralfato allo stato di gel secco
JP2705787B2 (ja) * 1994-09-30 1998-01-28 山之内製薬株式会社 苦味改善易服用性ｈ▲２▼ブロッカー固形製剤
TW469135B (en) * 1995-10-03 2001-12-21 Chugai Pharmaceutical Co Ltd Chewable tablet
WO1997019699A1 (fr) * 1995-11-27 1997-06-05 Yamanouchi Pharmaceutical Co., Ltd. Composition de medicament
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
AU9187598A (en) * 1997-09-30 1999-04-23 Daiichi Pharmaceutical Co., Ltd. Oral preparation
JP5524435B2 (ja) 1998-12-01 2014-06-18 ドクター レディーズ ラボラトリーズ リミティド 新規医薬組成物及びその調製のための方法
JP2002087965A (ja) * 2000-09-14 2002-03-27 Lion Corp 口中崩壊性アスピリン含有錠剤
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
EA024050B1 (ru) * 2010-04-23 2016-08-31 С-БИОТЕК ХОЛДИНГ АпС Твердая фармацевтическая композиция для нейтрализации желудочной кислоты
DE102014108502A1 (de) * 2014-06-17 2015-12-17 Gelita Ag Zusammensetzung in Form von kompaktierten Partikeln und deren Verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4446135A (en) * 1982-06-07 1984-05-01 Sterling Drug Inc. Chewable antacid tablets
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
DE69211688D1 (de) 1996-07-25
HUT65753A (en) 1994-07-28
DE69211688T2 (de) 1997-02-06
JPH06505498A (ja) 1994-06-23
BR9205824A (pt) 1994-06-28
AU665944B2 (en) 1996-01-25
CA2106216C (en) 1997-06-10
ATE139438T1 (de) 1996-07-15
HU9302971D0 (en) 1994-01-28
AU1674692A (en) 1992-11-02
EP0578732A1 (en) 1994-01-19
CZ225893A3 (en) 1994-04-13
EP0578732B1 (en) 1996-06-19
WO1992017161A1 (en) 1992-10-15
CA2106216A1 (en) 1992-10-05

Similar Documents

Publication Publication Date Title
US5629013A (en) Chewable calcium carbonate antacid tablet compositions
US5244670A (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
RU2493831C2 (ru) Фармацевтические композиции
SK121193A3 (en) Chewable antacid compositions
JP2001527518A (ja) 口腔組成物中の望ましくない味の抑制
KR19990063888A (ko) 저작정
EP1837019A1 (en) Orally-dispersible pharmaceutical compositions
HU219597B (hu) Javított ízű D-vitamin és kalciumtartalmú rágótabletta
TW201223522A (en) Formulations
HU211285A9 (en) Oral dosing formulations of dideoxy purine nucleosides
CA2474520C (en) Solid alginate compositions for use in treating gastric disorders
KR100238565B1 (ko) 상부 위장관 통증을 치료하기 위한 섭취가능한 약학적 조성물
CZ280566B6 (cs) Farmaceutický přípravek ve formě žvýkacích tablet nebo žvýkacích dražé, obsahující sukralfát
EP0415326B1 (en) Composition for foaming preparation
JPS6411008B2 (ja)
JPH05506238A (ja) 薬学的処方物
JPH0656677A (ja) 制酸剤組成物
JP5823131B2 (ja) 防風通聖散含有組成物
WO1996008238A1 (en) Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
RU2276982C2 (ru) Средство, обладающее противовоспалительным, анальгетическим, жаропонижающим действием в форме таблетки
WO2024023786A1 (en) Orally disintegrating palatable formulations of drotaverine and method of preparation thereof
CN116635013A (zh) 口腔可分散的粉末组合物
JP2021070685A (ja) 固形製剤
JPH10287555A (ja) チュアブル錠
WO1998024455A1 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress